Scarica l'app Stockscreener
332.27
1.20%
3.93
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché KRYS Giù?
Forum
Previsione
Krystal Biotech Inc Borsa (KRYS) Ultime notizie
State of Wyoming Buys New Stake in Krystal Biotech, Inc. $KRYS - MarketBeat
Should Surging Vyjuvek-Driven Earnings Reshape How Krystal Biotech (KRYS) Investors View Its Risk Profile? - simplywall.st
Krystal Biotech (NASDAQ:KRYS) Upgraded to "Moderate Buy" at Royal Bank Of Canada - MarketBeat
Krystal Biotech (KRYS) Director Dino Rossi Sells 25,000 Shares - GuruFocus
Krystal Biotech(KRYS.US) Director Sells US$8.23 Million in Common Stock - moomoo.com
Krystal Biotech (NASDAQ:KRYS) director Dino Rossi sells $8.2m shares - Investing.com
Dino Rossi Sells 25,000 Shares of Krystal Biotech (NASDAQ:KRYS) Stock - MarketBeat
Krystal Biotech, Inc. SEC Filing (Aug 14, 2026) - Stock Titan
RBC Capital Initiates Krystal Biotech(KRYS.US) With Buy Rating, Announces Target Price $400 - moomoo.com
KRYS Looks 0.5% Undervalued on GF Value™ - GuruFocus
Krystal Biotech Seen Positioned for Further Gains on Vyjuvek, Pipeline Readouts, RBC Says - marketscreener.com
KRYS Initiates Coverage by RBC Capital -- Rating Set to Outperfo - GuruFocus
Krystal Bio wins bullish view at RBC Capital Markets (KRYS) - Seeking Alpha
KRYS Stock Rallies On Upbeat Earnings: Jefferies Ups Price Target On Sustained Vyjuvek Optimism - Stocktwits
Here Are Friday’s Top Wall Street Analyst Research Calls: Cinemark, Digital Realty, Fox Corporation, Krystal Biotech, LTC Properties, Roku, Sandisk, T-Mobile US, Wayfair, and More - Yahoo Finance
RBC Initiates Krystal Biotech at Outperform, With $400 Price Target - marketscreener.com
KRYSTAL BIOTECH, INC. : RBC INITIATES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE $400 - Bitget
Krystal Biotech (KRYS) Earnings And Pipeline Progress Put Valuation Back In Focus - sahmcapital.com
Krystal Biotech, Inc. (KRYS) Stock forecasts - Yahoo Finance UK
Wolfe Research Maintains Krystal Biotech(KRYS.US) With Hold Rating - Moomoo
Trading Systems Reacting to (KRYS) Volatility - news.stocktradersdaily.com
Bank of America Corp DE Increases Stock Position in Krystal Biotech, Inc. $KRYS - MarketBeat
Krystal Biotech (KRYS) Q2 2026 Earnings Call Transcript - The Globe and Mail
If You Invested $1000 In Krystal Biotech Stock 5 Years Ago, You Would Have This Much Today - Benzinga
Renaissance Technologies LLC Has $2.48 Million Stock Position in Krystal Biotech, Inc. $KRYS - MarketBeat
Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring a 17% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
Krystal Biotech (KRYS) Stock May Be Fully Valued After Its 5x Run - Yahoo Finance
Krystal Biotech Inc (KRYS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Krystal Biotech (NASDAQ:KRYS) Upgraded at Chardan Capital - MarketBeat
Krystal Biotech, Inc. (KRYS) Stock Forecasts - Yahoo Finance
California State Teachers Retirement System Has $6.76 Million Holdings in Krystal Biotech, Inc. $KRYS - marketbeat.com
Krystal Biotech, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:KRYS) 2026-08-05 - Seeking Alpha
Krystal Biotech (KRYS) After Its Q2 Beat Is The Valuation Case Still Intact - sahmcapital.com
Krystal Q2 Earnings & Sales Beat Estimates, Pipeline in Focus - Yahoo Finance
Citi Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $386 - Moomoo
Krystal Biotech, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Brokers Issue Forecasts for Krystal Biotech FY2026 Earnings - MarketBeat
Krystal Biotech Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Krystal Biotech Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus
Krystal Biotech Inc (KRYS) (Q2 2026) Earnings Call Highlights: VYJUVEK Sales Surge 24% as ... By GuruFocus - Investing.com Canada
Krystal Biotech Inc (KRYS) (Q2 2026) Earnings Call Highlights: V - GuruFocus
Is Krystal Biotech (KRYS) Overvalued After Q2 Earnings Beat? EPS of $1.85 & Revenue of $119.2M; GF Score: 54/100 - GuruFocus
Why Is Krystal Biotech (KRYS) Dropping 7.0%? - AlphaStreet
Krystal Biotech stock falls 7% on revenue miss despite earnings beat - Investing.com South Africa
krystal biotech vyjuvek revenue rises 24 percent - grafa.com
Krystal Biotech (NASDAQ:KRYS) Shares Gap DownHere's What Happened - MarketBeat
Krystal Biotech Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Q2 2026 Krystal Biotech Inc Earnings Call Transcript - GuruFocus
Krystal Biotech, Inc. (KRYS) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results - The Manila Times
Earnings Flash (KRYS) Krystal Biotech Posts Q2 EPS $1.79, vs. FactSet Est of $1.62 - marketscreener.com
Earnings Flash (KRYS) Krystal Biotech, Inc. Reports Q2 Revenue $119.2M, vs. FactSet Est of $120.9M - marketscreener.com
Krystal Biotech Reports Strong 2Q 2026 VYJUVEK Revenue Growth and Advances Multi-Program Genetic Medicines Pipeline - Quiver Quantitative
Krystal Biotech Q2 Earnings Beat Expectations - Intellectia AI
Krystal Biotech Q2 revenue rises on VYJUVEK strength - TradingView
Krystal Biotech 2Q 2026: Revenue $119.22M, EPS $1.79— 10-Q Summary - TradingView
Krystal Biotech Q2 revenue rises to $119.2 million on VYJUVEK sales - Quiver Quantitative
Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring A Promising 12.70% Upside - directorstalkinterviews.com
Healthcare of Ontario Pension Plan Trust Fund Purchases Shares of 4,664 Krystal Biotech, Inc. $KRYS - MarketBeat
Sei Investments Co. Has $12.03 Million Stake in Krystal Biotech, Inc. $KRYS - MarketBeat
Krystal Biotech Drops 5.9% Amid Sector-Wide Selling - AlphaStreet
Krystal Biotech earnings in focus as Vyjuvek expansion accelerates By Investing.com - Investing.com Canada
Krystal Biotech slides as investors appear to reset ahead of earnings - Quiver Quantitative
Krystal Biotech (KRYS) Could Be 40% Overvalued As KB801 News Tests Its Price - Yahoo Finance
Krystal Biotech: Profitable, Self-Funding, And Loaded With Optionality (NASDAQ:KRYS) - Seeking Alpha
Krystal Biotech, Inc. $KRYS Shares Sold by Dimensional Fund Advisors LP - MarketBeat
Krystal Biotech Inc (KRYS) Institutional Confidence - TradingKey
Krystal Biotech Inc (KRYS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Krystal Biotech Inc (KRYS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Krystal Biotech, Inc. (KRYS) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Krystal Biotech, Inc. (KRYS) Stock Analysis: Biotechnology Pioneer with 12.40% Potential Upside - DirectorsTalk Interviews
0.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):